Business Description
Nemaura Medical Inc
NAICS : 339112
SIC : 5047
ISIN : US6404422080
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | -3.45 | |||||
Debt-to-Equity | -1.1 | |||||
Debt-to-EBITDA | -4.37 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -8.9 | |||||
3-Year EPS without NRI Growth Rate | -44.7 | |||||
3-Year FCF Growth Rate | -27.1 | |||||
3-Year Book Growth Rate | -86.5 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 25.63 | |||||
9-Day RSI | 31.84 | |||||
14-Day RSI | 34.57 | |||||
6-1 Month Momentum % | -80.1 | |||||
12-1 Month Momentum % | -88.72 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.19 | |||||
Quick Ratio | 0.03 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 644.11 | |||||
Days Payable | 75.37 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -11.5 | |||||
Shareholder Yield % | 74.42 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
FCF Margin % | -12576.39 | |||||
ROA % | -106.37 | |||||
ROIC % | -56.93 | |||||
3-Year ROIIC % | -20.92 | |||||
ROC (Joel Greenblatt) % | -386.72 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 9.33 | |||||
EV-to-EBIT | -4.14 | |||||
EV-to-EBITDA | -4.59 | |||||
EV-to-Revenue | 267.99 | |||||
EV-to-Forward-Revenue | 6.83 | |||||
EV-to-FCF | -2.12 | |||||
Earnings Yield (Greenblatt) % | -24.15 | |||||
FCF Yield % | -862.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Nemaura Medical Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.072 | ||
EPS (TTM) (€) | -0.298 | ||
Beta | 0 | ||
Volatility % | 84.65 | ||
14-Day RSI | 34.57 | ||
14-Day ATR (€) | 0.017978 | ||
20-Day SMA (€) | 0.1561 | ||
12-1 Month Momentum % | -88.72 | ||
52-Week Range (€) | 0.103 - 2.464 | ||
Shares Outstanding (Mil) | 28.9 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Nemaura Medical Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Nemaura Medical Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Nemaura Medical Inc Frequently Asked Questions
What is Nemaura Medical Inc(STU:N18A)'s stock price today?
When is next earnings date of Nemaura Medical Inc(STU:N18A)?
Does Nemaura Medical Inc(STU:N18A) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |